Jennison Associates
MD icon

Jennison Associates’s Pediatrix Medical MD Stock Holding History

Jennison Associates’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Sell
52,822
-8,024
-13% -$183K ﹤0.01% 481
2026
Q1 		$1.3M Buy
60,846
+24,950
+70% +$519K ﹤0.01% 473
2025
Q4 		$768K Buy
+35,896
New +$736K ﹤0.01% 531
2021
Q4 		– Sell
-33,111
Closed -$941K – 700
2021
Q3 		$941K Buy
+33,111
New +$1.01M ﹤0.01% 619

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Jennison Associates's MD Position: Q2 2026 in Review

Jennison Associates reduced its Pediatrix Medical (MD) stake by 13% in Q2 2026, selling an estimated $183K and leaving 52,822 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #481.

Jennison Associates first reported a position in MD in Q3 2021 and has held it in 4 quarters since. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Jennison Associates held 52,822 shares of Pediatrix Medical worth $1.34M as of Q2 2026.
  • Jennison Associates sold 8,024 Pediatrix Medical shares in Q2 2026, an estimated $183K.
  • Pediatrix Medical made up ﹤0.01% of Jennison Associates's portfolio in Q2 2026, its #481 holding.
  • Jennison Associates first reported a position in Pediatrix Medical in Q3 2021 and has held it in 4 quarters since.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.